Publication | Closed Access

Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial

InflammationCcr5 Antagonist MaravirocAutoimmune DiseaseTreatment And PreventionImmunologyClinical TrialsInflammatory MarkerAutoimmunityPlacebo-controlled TrialChronic Viral InfectionHivMedicineInflammatory Disease